The detection of fFN in cervical and vaginal secretions between weeks 22 and 34 of gestation can be a significant indicator. When fFN is present during this period, it may suggest an increased risk of preterm labor. Thus, it serves as a useful biomarker in evaluating the risk of premature birth.
